Bull
$155.23
Scenario price
$142.200
-2.403 (-1.69%)At close
Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others.
Currently, Novanta Inc. (NOVT) is trading at $142.20, which is below the analyst price target of $194, indicating potential upside. However, the RSI is at a low 33.05, suggesting the stock is oversold and may not be a strong buy at this moment. The main risk is the insider selling activity, which has increased by 134.30% over the last month, indicating potential concerns from insiders about the stock's future performance.
Baird
$194
2026-08-07
Baird
2026-08-07
Price Target
$194
Baird
$173
2026-05-13
Baird
2026-05-13
Price Target
$173
Baird
$144
2026-03-30
Baird
2026-03-30
Price Target
$144
Baird
$150
2026-02-25
Baird
2026-02-25
Price Target
$150
Baird
$133
2025-08-11
Baird
2025-08-11
Price Target
$133
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Novanta Executives to Present at Baird Global Healthcare Conference

Novanta (NOVT) Q2 2026 Earnings Call Transcript

Novanta to Release Q2 2026 Results and Host Conference Call

Novanta Executives to Present at CJS Securities Conference

Novanta Executives to Present at CJS Securities Conference
Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others. It operates in the Technology sector (MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SU industry).
Currently, Novanta Inc. (NOVT) is trading at $142.20, which is below the analyst price target of $194, indicating potential upside. However, the RSI is at a low 33.05, suggesting the stock is oversold and may not be a strong buy at this moment. The main risk is the insider selling activity, which has increased by 134.30% over the last month, indicating potential concerns from insiders about the stock's future performance.
1 analysts cover NOVT: 1 rate it Buy, 0 Hold and 0 Sell.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.